June 21, 2024
CCH registration is OPEN!
Demonstrate your commitment to your patients and practice at APC’s annual DC fly-in for pharmacy compounders, September 17-18 at Hilton National Mall.
June 21, 2024
Demonstrably difficult list, demonstrably problematic
The FDA is proposing a rule that would add categories to both the 503A and 503B demonstrably difficult to compound (DDC) lists — a plan that has a host of issues.
June 21, 2024
APC to CA BOP: How does this make patients safer?
The California Board of Pharmacy has proposed several new regulations for pharmacy compounding, some of which, to put it bluntly (and we did put it bluntly), are not rooted in science or evidence.
December 1, 2023
PCF names new directors
The Pharmacy Compounding Foundation has elected five board members
December 1, 2023
Our state-by-state 795-797-800 chart has been updated
APC has posted an updated version of our compilation of state by state adoption of USP <795>, <797>, and <800>.
December 1, 2023
Novo alleges potency discrepancy, impurities in compounded semaglutide
We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no?
December 1, 2023
APC files amicus in Novo case against Tennessee compounder
A U.S. District Court judge approved APC filing an amicus brief this week in Novo Nordisk’s lawsuit against Tennessee compounder (and APC PFM) DCA Pharmacy.
December 1, 2023
A $100,000 deficit
One of the challenges of being an ambitious but resource-poor association is that we have to spend a lot of time asking members like you for money.
November 30, 2023
Telling your story, one reporter at a time
The photo inset below on the left was taken last Friday morning at Preston’s Pharmacy (a PFM, I might add) in Arlington, Virginia. It’s not a pharmacist or technician in the photo. It’s a healthcare reporter.
